Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SELEXID - Health Canada Drug Approval Details

Approvals/Health Canada/SELEXID

Authorized

STANDARD

SELEXID

KARO HEALTHCARE AB🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 5b9312ef9a66d2c7
Company: KARO HEALTHCARE AB
Type: Standard

Approval Details

Approval Id: 5b9312ef9a66d2c7
Drug Approval Canada Name: SELEXID
Product Name: SELEXID
Status: Approved
Status Date: 2024-02-01
Din: 02456664
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:12.16
Atc Original: J01CA08 PIVMECILLINAM
Atc Name: j 01 ca 08
Aig Number: 0158390001
Company Name: KARO HEALTHCARE AB
Company Address: Po Box 16184, Stockholm, --, Sweden, 10324
Company Detail Path: /organization/karo-healthcare-ab

Company Information

Pharmaceutical Company Name: KARO HEALTHCARE AB
Country Name: Sweden
City Name: maidenhead,country_gb
Address: C/O Karo Healthcare Uk Limited
Website: http://www.karobio.se

Active Ingredients

PIVMECILLINAM HYDROCHLORIDE

200 MG

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

5b9312ef9a66d2c7

Type

Standard

Back to Health Canada Approvals